Bezirkskliniken Schwaben
- Address
- Geschwister-Schoenert-Strasse 4, 86156 Augsburg, Germany
Bezirkskliniken Schwaben - Psychiatric Treatment Optimization Research
Bezirkskliniken Schwaben is a specialized psychiatric research center focused on advancing treatment strategies for severe mental health disorders. The center demonstrates particular expertise in investigating innovative pharmacological interventions for patients who have not responded adequately to initial treatment approaches, addressing a critical gap in psychiatric care.
- Treatment-resistant schizophrenia and related psychotic disorders including schizoaffective and schizophreniform disorders
- Major depressive disorder with focus on treatment failure scenarios
- Bipolar disorder (Type I and II) with emphasis on depressive episodes
- Early treatment intensification strategies following first-line therapy failure
The center's research approach emphasizes comparative effectiveness studies that evaluate intensified pharmacological interventions against standard treatment protocols. By conducting randomized controlled trials across multiple psychiatric diagnoses, Bezirkskliniken Schwaben contributes valuable evidence for optimizing therapeutic pathways when patients experience their first treatment failure, ultimately working toward improved outcomes in mood and psychotic disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Bezirkskliniken Schwaben
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major depressive disorder and bipolar depression compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment. | Universitair Medisch Centrum Utrecht | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bupropion Hydrochloride | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.